Published in J Urol on July 01, 1975
A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype. J Theor Biol (2007) 1.37
Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre. BJU Int (2015) 0.87
Metastatic squamous cell carcinoma of the kidney from cholangiocarcinoma. World J Mens Health (2012) 0.80
Renal metastasis after esophagectomy of esophageal squamous cell carcinoma: a case report and literature review. World J Surg Oncol (2014) 0.79
Common and uncommon bilateral adult renal masses. Cancer Imaging (2012) 0.78
Intraglomerular metastasis: a necropsy study. J Clin Pathol (1999) 0.78
Nephrectomy for a renal metastasis of undiagnosed hepatocellular carcinoma arising from an orthotopic liver transplant undertaken for cryptogenic cirrhosis. Korean J Urol (2013) 0.75
Carcinoma of the lungs causing enlarged kidneys. Proc (Bayl Univ Med Cent) (2015) 0.75
Late recurrence of colorectal adenocarcinoma as a renal tumour by direct spread via the ureter. Ther Adv Urol (2017) 0.75
A rare case of asymptomatic radioiodine-avid renal and brain metastases 20 years after hemi-thyroidectomy for adenomatous goiter. Indian J Nucl Med (2016) 0.75
Renal metastasis from cervical carcinoma presenting as a renal cyst: A case report. Oncol Lett (2015) 0.75
Solitary renal metastasis of esophageal squamous cell carcinoma mimicking primary renal neoplasm - A case report and literature review. Biomedicine (Taipei) (2016) 0.75
Intraglomerular micrometastasis of squamous cell carcinoma. Clin Kidney J (2012) 0.75
A rare case of renal metastasis from squamous cell carcinoma of the cervix. J Midlife Health (2016) 0.75
Kidney metastasis of resected early gastric carcinoma: report of a case. Surg Today (2007) 0.75
'Green revolution' genes encode mutant gibberellin response modulators. Nature (1999) 8.87
The Arabidopsis GAI gene defines a signaling pathway that negatively regulates gibberellin responses. Genes Dev (1997) 7.30
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg (1978) 3.37
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer (1980) 3.37
Purification of a human prostate specific antigen. Invest Urol (1979) 3.11
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin (1993) 2.43
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer (1998) 2.15
Noninvasive, real-time monitoring of renal function: the ambulatory renal monitor. J Nucl Med (1993) 2.11
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology (1998) 2.04
Physicians' opinions on the delivery of mammographic screening services: immediate interpretation versus double reading. AJR Am J Roentgenol (1996) 2.04
American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77
Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer (1985) 1.76
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation (1977) 1.73
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate (1999) 1.71
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer (1999) 1.58
Clinical highlights from the National Cancer Data Base: 1994. CA Cancer J Clin (1994) 1.58
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli. J Gen Microbiol (1992) 1.48
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer (1997) 1.47
Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1994) 1.46
Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis. Obes Rev (2009) 1.46
Should women with implants or a history of treatment for breast cancer be excluded from mammography screening programs? AJR Am J Roentgenol (1997) 1.43
Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer (1981) 1.40
The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer (1991) 1.39
Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer (1988) 1.35
Metastatic carcinomas from occult primary tumors. A study of 254 patients. Ann Surg (1977) 1.34
CEA as a monitor of gastrointestinal malignancy. Cancer (1975) 1.33
Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. Mol Pharmacol (2000) 1.32
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol (1998) 1.29
Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol (1986) 1.29
Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg (1980) 1.27
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer. Cancer (1993) 1.27
Uranium in the tissues of an occupationally exposed individual. Health Phys (1989) 1.25
The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1996) 1.25
Acquired tracheomalacia: detection by expiratory CT scan. J Comput Assist Tomogr (2001) 1.23
The association of benign prostatic hyperplasia and cancer of the prostate. Cancer (1992) 1.22
Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy. J Clin Microbiol (1999) 1.21
Vascular catheter-related Comamonas acidovorans bacteremia managed with preservation of the catheter. Pediatr Infect Dis J (1996) 1.20
Prostate antigen: a new potential marker for prostatic cancer. Prostate (1981) 1.18
In vitro and in vivo persistence of reticulocytes from donor red cells. Transfusion (1996) 1.17
Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate Suppl (1996) 1.17
Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor. Br J Pharmacol (1998) 1.16
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1996) 1.13
Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution. Mol Pharmacol (1996) 1.13
Correlations of the orthogonal electrocardiogram and vectorcardiogram with consitutional variables in 518 normal men. Circulation (1967) 1.12
Familial dysautonomia differentiated from related disorders. Case reports and discussions of current concepts. Pediatrics (1966) 1.12
Follow-up evaluation of a phase II prostate cancer vaccine trial. Prostate (1999) 1.11
Automated detection of microcalcification clusters for digital breast tomosynthesis using projection data only: a preliminary study. Med Phys (2008) 1.11
Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res (1981) 1.10
Acute accidental inhalation of U: a 38-year follow-up. Health Phys (1986) 1.09
A murine renal cell carcinoma. J Natl Cancer Inst (1973) 1.09
Why is the prostate cancer death rate declining in the United States? Cancer (1998) 1.09
A clinicopathologic study of prognostic factors in cutaneous malignant melanoma. Surg Gynecol Obstet (1977) 1.09
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate (1998) 1.09
A prostate antigen in sera of prostatic cancer patients. Cancer Res (1980) 1.08
Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity. J Biol Chem (1999) 1.07
Lysosome proteins are redistributed during expression of a GTP-hydrolysis-defective rab5a. J Cell Sci (2001) 1.07
Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years. Radiology (1996) 1.07
Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons. Ann Surg (1978) 1.07
Prostate cancer: progress and change. CA Cancer J Clin (1978) 1.06
The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer (1979) 1.05
Acute changes in cardiopulmonary blood volume during upright exercise stress testing in patients with coronary heart disease. Circulation (1979) 1.05
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate (1997) 1.05
A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer (1997) 1.05
Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin (1993) 1.05
Prostate-specific membrane antigen: current and future utility. Semin Urol Oncol (1998) 1.04
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res (1980) 1.04
The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer (1996) 1.04
Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology (2000) 1.04
The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol (1982) 1.04
American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin (1997) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Method for identifying prostate cells in semen using flow cytometry. Prostate (1998) 1.04
Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin. J Urol (1975) 1.03
Chemotherapy programs of the National Prostatic Cancer Project (NPCP). Cancer (1980) 1.03
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03
Stroke volume and cardiac output decrease at termination of obstructive apneas. J Appl Physiol (1985) (1992) 1.02
Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. J Urol (1994) 1.02
Fibrin degradation products in renal parenchymal disease states and renal transplant patients. Transplantation (1972) 1.02
An assessment of the current use of human interferons in therapy of urological cancers. J Urol (1989) 1.01
Primary liver tumors and oral contraceptives. Results of a survey. JAMA (1977) 1.01
Search for BK and SV40 virus reactivation in renal transplant recipients. Transplantation (1974) 1.01
American Cancer Society guidelines for the early detection of prostate cancer: update, June 10, 1997. Cancer (1997) 1.00
Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial. Cancer Res (2000) 1.00
Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst (1981) 1.00
Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin (1992) 1.00
Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate (1998) 1.00
Prostate cancer in blacks: an update from the American College of Surgeons' patterns of care studies. J Surg Oncol (1989) 1.00
Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project. J Urol (1994) 1.00
Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses. Int J Obes (Lond) (2010) 0.99
Hormonal therapy in advanced renal cell carcinoma. Cancer (1971) 0.98